These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36890486)

  • 1. Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
    Kamiya H; Komatsu S; Nishibeppu K; Ohashi T; Konishi H; Shiozaki A; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    BMC Cancer; 2023 Mar; 23(1):218. PubMed ID: 36890486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer.
    Komatsu S; Ichikawa D; Nishimura M; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Eur J Surg Oncol; 2017 Jan; 43(1):203-209. PubMed ID: 27595506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.
    Komatsu S; Ichikawa D; Miyamae M; Kosuga T; Okamoto K; Arita T; Konishi H; Morimura R; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
    J Gastrointest Surg; 2016 Sep; 20(9):1565-71. PubMed ID: 27353383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y; Liu D; Zeng D; Chen C
    J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
    Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.